Comparison of Tumor Control and Toxicity Outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients With Favorable Risk Prostate Cancer-Reference-Cited by-同舟云学术

Comparison of Tumor Control and Toxicity Outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients With Favorable Risk Prostate Cancer

Published:2011-04 Issue:4 Volume:77 Page:986-990
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Zelefsky Michael J.,Yamada Yoshiya,Pei Xin,Hunt Margie,Cohen Gilad,Zhang Zhigang,Zaider Marco

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial;Pollack;Int J Radiat Oncol Biol Phys,2002

2. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial;Zietman;JAMA,2005

3. Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer;Zelefsky;J Urol,2006

4. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer;Kupelian;Int J Radiat Oncol Biol Phys,2008

5. Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancer;Yamada;Brachytherapy,2006

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of perioperative and subacute postoperative complications between LDR and HDR monotherapy brachytherapy for prostate cancer;Brachytherapy;2024-09

2. Overview of Radiation Therapy in the Management of Localized and Metastatic Prostate Cancer;Current Urology Reports;2024-06-11

3. The oncologic and safety outcomes of low-dose-rate brachytherapy for the treatment of prostate cancer;Prostate International;2023-09

4. Clinical and treatment characteristics of secondary bladder malignancies following low dose rate brachytherapy for prostate cancer;Urologic Oncology: Seminars and Original Investigations;2023-06

5. Long-term oncologic outcomes of low dose-rate brachytherapy compared to hypofractionated external beam radiotherapy for intermediate -risk prostate cancer;Brachytherapy;2023-03